C07D 215/54
Attached in position 3
Official title: attached in position 3
C07D215/54 (Attached in position 3) appears on 1,077 US grants and 895 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,077
- Published applications
- 895
- Assignees
- 487
- Inventors
- 3,018
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 7 | 0 |
| 1978 | 5 | 0 |
| 1979 | 10 | 0 |
| 1980 | 7 | 0 |
| 1981 | 13 | 0 |
| 1982 | 5 | 0 |
| 1983 | 7 | 0 |
| 1984 | 14 | 0 |
| 1985 | 20 | 0 |
| 1986 | 14 | 0 |
| 1987 | 20 | 0 |
| 1988 | 32 | 0 |
| 1989 | 25 | 0 |
| 1990 | 32 | 0 |
| 1991 | 29 | 0 |
| 1992 | 22 | 0 |
| 1993 | 24 | 0 |
| 1994 | 18 | 0 |
| 1995 | 22 | 0 |
| 1996 | 31 | 0 |
| 1997 | 33 | 0 |
| 1998 | 25 | 0 |
| 1999 | 14 | 0 |
| 2000 | 20 | 0 |
| 2001 | 22 | 3 |
| 2002 | 27 | 27 |
| 2003 | 23 | 31 |
| 2004 | 26 | 47 |
| 2005 | 12 | 49 |
| 2006 | 25 | 48 |
| 2007 | 31 | 50 |
| 2008 | 30 | 33 |
| 2009 | 23 | 34 |
| 2010 | 24 | 44 |
| 2011 | 24 | 32 |
| 2012 | 20 | 40 |
| 2013 | 37 | 45 |
| 2014 | 45 | 62 |
| 2015 | 49 | 47 |
| 2016 | 25 | 35 |
| 2017 | 27 | 37 |
| 2018 | 18 | 25 |
| 2019 | 26 | 23 |
| 2020 | 15 | 40 |
| 2021 | 24 | 24 |
| 2022 | 21 | 25 |
| 2023 | 14 | 30 |
| 2024 | 16 | 30 |
| 2025 | 16 | 21 |
| 2026 | 4 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for treating muscular dystrophies22 Sep 2026US 12,741,939 B2The Regents of the University of California
- Crystal form of quinolinone compound and use thereof25 Aug 2026US 12,715,846 B2Sunshine Lake Pharma Co., Ltd.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Quinoline derivatives24 Feb 2026US 12,559,481 B2Elanco Animal Health GmbH
- Nitroxoline derivative, preparation method therefor, and use thereof23 Dec 2025US 12,503,440 B2Asieris Pharmaceuticals (Shanghai) Co., Ltd.
- Hydroxylamine-based bcr-abl1 inhibitors for treatment of cancer1 Oct 2026US 2026/0297031 A1University of Georgia Research Foundation, Inc.
- New phenylquinolone compound having antibacterial and anti-cancer functions and preparation thereof6 Aug 2026US 2026/0224555 A1AlphaMol Science Ltd (Shanghai)
- Compounds and their use9 Jul 2026US 2026/0191999 A1King's College London
- HIPK4 Degraders as Non-Hormonal Male Contraceptives14 May 2026US 2026/0130902 A1Sanford Burnham Prebys Medical Discovery Institute
- Methods for treating cancer14 May 2026US 2026/0130925 A1Genesis Molecular AI, Inc.
Most cited
By later US patents
- Substituted 3-cyano quinolines164US 6,002,008 AAmerican Cyanamid Company · 1999
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs119US 4,760,057 AMerck & Co., Inc. · 1988
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009
- Quinoline compounds117US 5,650,415 ASugen, Inc. · 1997